Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types

Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types

Background: Substantial heterogeneity has been reported in efficacy against high-grade cervical intraepithelial neoplasia (CIN) irrespective of HPV type in phase III results for bivalent and quadrivalent human papillomavirus virus (HPV) vaccines (AS04-HPV and qHPV). Real-world data recently confirme...

Full description

Bibliographic Details
Main Authors: Martin Ryser, Valérie Berlaimont, Naveen Karkada, Attila Mihalyi, Rino Rappuoli, Robbert van der Most
Format: Article
Language:English
Published: Taylor & Francis Group 2019-03-01
Series:Expert Review of Vaccines
Subjects:
as04-adjuvanted hpv-16/18 vaccine
cervical cancer
cervical intraepithelial neoplasia
cross-protection
human papillomavirus
Online Access:http://dx.doi.org/10.1080/14760584.2019.1579647

Internet

http://dx.doi.org/10.1080/14760584.2019.1579647

Similar Items